Improved Appropriateness of Advanced Diagnostic Imaging After Implementation of Clinical Decision Support Mechanism.

Leonid L Chepelev¹, Xuan Wang², Benjamin Gold³, Clara-Lea Bonzel², Frank Rybicki⁴, Jennifer W Uyeda⁴, Adnan Sheikh⁵, Dan Anderson³, Jared Lindaman³, Greg Mogel³, Dimitrios Mitsouras⁶, Mary C Mahoney⁷, Tianxi Cai², Frank J Rybicki⁸

¹Stanford University, Stanford, CA, USA.

²Harvard School of Public Health, Boston, MA, USA.

³Change Healthcare, Madison, WI, USA.

⁴Harvard Medical School, Boston, MA, USA.

⁵University of Ottawa, Ottawa, Ontario, Canada.

⁶University of California San Francisco, San Francisco, CA, USA.

⁷University of Cincinnati, Cincinnati, Ohio, USA.

⁸University of Cincinnati, Cincinnati, Ohio, USA. rybickfk@ucmail.uc.edu.

PubMed PMC DOI PDF

Abstract

The Protecting Access to Medicare Act (PAMA) mandates clinical decision support mechanism (CDSM) consultation for all advanced imaging. There are a growing number of studies examining the association of CDSM use with imaging appropriateness, but a paucity of multicenter data. This observational study evaluates the association between changes in advanced imaging appropriateness scores with increasi…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.